Patents by Inventor Louwe De Vries

Louwe De Vries has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS FOR USE IN THE TREATMENT OF CANCER
    Publication number: 20220257698
    Abstract: The present invention relates to the cyclic peptides that are agonists of the angiotensin II type 2 receptor (hereinafter the AT2 receptor) useful in the treatment of different types of solid cancer, in particular brain, colon, lung and ovarian cancer. The invention further relates to pharmaceutical compositions containing them and uses thereof for the treatment of cancer.
    Type: Application
    Filed: August 3, 2020
    Publication date: August 18, 2022
    Inventors: Pawel Namsolleck, Anneke Kuipers, Louwe De Vries, Claudio Festuccia
  • NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20190135867
    Abstract: The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
    Type: Application
    Filed: January 14, 2019
    Publication date: May 9, 2019
    Inventors: Louwe De Vries, Sieger Adriaan Nelemans, Rick Rink, Antonius Jacobus Marinus Roks, Gert Nikolaas Moll
  • Angiotensin type 2 (AT2) receptor agonists and uses thereof
    Patent number: 10214563
    Abstract: The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: February 26, 2019
    Assignee: LANTHIOPEP B.V.
    Inventors: Louwe De Vries, Sieger Adriaan Nelemans, Rick Rink, Antonius Jacobus Marinus Roks, Gert Nikolaas Moll
  • NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20170283465
    Abstract: The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
    Type: Application
    Filed: June 8, 2017
    Publication date: October 5, 2017
    Inventors: Louwe De Vries, Sieger Adriaan Nelemans, Rick Rink, Antonius Jacobus Marinus Roks, Gert Nikolaas Moll
  • Angiotensin type 2 (AT2) receptor agonists and uses thereof
    Patent number: 9707268
    Abstract: The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: July 18, 2017
    Assignee: LANTHIOPEP B.V.
    Inventors: Louwe De Vries, Sieger Adriaan Nelemans, Rick Rinck, Antonius Jacobus Marinus Roks, Gert Nikolaas Moll
  • Novel Angiotensin Type 2 (AT2) Receptor Agonists and Uses Thereof
    Publication number: 20160220632
    Abstract: The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
    Type: Application
    Filed: January 29, 2016
    Publication date: August 4, 2016
    Inventors: Louwe De Vries, Sieger Adriaan Nelemans, Rick Rinck, Antonius Jacobus Marinus Roks, Gert Nikolaas Moll
  • Angiotensin Type 2 (AT2) receptor agonists and uses thereof
    Patent number: 9290540
    Abstract: The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
    Type: Grant
    Filed: November 22, 2011
    Date of Patent: March 22, 2016
    Assignee: Lanthio Pep B.V.
    Inventors: Louwe De Vries, Sieger Adriaan Nelemans, Rick Rink, Antonius Jacobus Marinus Roks, Gert Nikolaas Moll
  • Novel Angiotensin Type 2 (AT2) Receptor Agonists and Uses Thereof
    Publication number: 20140094400
    Abstract: The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
    Type: Application
    Filed: November 22, 2011
    Publication date: April 3, 2014
    Applicant: LANTHIOPEP B.V.
    Inventors: Louwe De Vries, Sieger Adriaan Nelemans, Rick Rink, Antonius Jacobus Marinus Roks, Gert Nikolaas Moll